ArticleInfection and drug resistance2025
Impact of the COVID-19 Pandemic on Pediatric Pneumonia Outcomes: A Five-Year Retrospective Cohort Study.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pneumonia remains a leading cause of pediatric morbidity globally, with Objective: Primary objectives: Examine epidemiological trends in pediatric pneumonia (2019-2023) and evaluate surgical treatment outcomes. Secondary objectives: Analyze demographic and clinical characteristics, assess treatment response patterns and investigate factors associated with complicated disease courses. Methods: A retrospective, single-center study was conducted at Thomayer University Hospital, Prague, Czech Republic, analysing medical records of children diagnosed with pneumonia in years 2019-2024. Data highly suggestive to Results: We collected a total of 305 pediatric patients with community-acquired pneumonia (CAP). A total of 181 patients out of all CAP patients (59.3%) were suspected from pneumococcal aethiology. About 12.1% were identified as complicated. The statistical models showed significant increases over time (P < 0.05), with the complication rate rising by 0.143 per year ( Conclusion: This study highlights a rising incidence of bacterial pneumonia, mainly pneumococcal, and its severe forms in children, particularly after the emergence of the pandemic. The findings underscore the need for a multidisciplinary approach and the role of minimally invasive surgical techniques in managing complex cases. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.